Secretory phospholipase A2 (sPLA2) as prognostic and diagnostic marker for cardiovascular diseases
摘要
<p>The present invention relates to a method for determining an increased risk of mortality or of a cardiac and/or vascular event in a patient, comprising: - determining the sPLA2 activity of said patient, - comparing said activity to a predetermined value, a higher sPLA2 activity of said patient as compared to said predetermined value being indicative of an increased risk of mortality or of a cardiac and/or vascular event.</p>
申请公布号
EP2077332(A1)
申请公布日期
2009.07.08
申请号
EP20080173028
申请日期
2005.07.15
申请人
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE);L'ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS;UNIVERSITE PARIS DIDEROT - PARIS 7
发明人
MALLAT, ZIAD;TEDGUI, ALAIN;STEG, PHILIPPE GABRIEL;FREYSSINET, JEAN-MARIE;BENESSIANO, JOELLE